Lexicon Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Lexicon Pharmaceuticals, Inc. (LXRX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.070.020.140.090.130.270.16
Short-Term Investments0.170.150.090.020.030.000.00
Cash & Short-Term Investments0.240.170.140.090.150.270.16
Accounts Receivable0.000.000.000.000.000.060.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.010.000.000.010.010.00
Total Current Assets0.250.180.140.090.160.340.17
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.000.000.010.02
Goodwill0.040.040.040.040.040.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.050.050.050.050.050.080.11
Total Assets0.300.230.190.130.200.420.28
Current Liabilities
Accounts Payable0.010.010.020.020.010.050.03
Short-Term Debt0.000.000.000.000.010.000.00
Current Portion of Long-Term Debt0.000.000.000.000.010.000.00
Accrued Liabilities0.010.020.010.010.030.000.00
Other Current Liabilities0.030.010.010.000.000.000.00
Total Current Liabilities0.050.030.020.020.050.070.04
Non-Current Liabilities
Long-Term Debt0.100.100.050.000.000.230.24
Other Non-Current Liabilities0.000.000.010.000.000.000.00
Total Non-Current Liabilities0.110.100.050.000.000.240.27
Total Liabilities0.150.140.080.020.050.300.31
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.97-1.77-1.59-1.49-1.40-1.34-1.47
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Treasury Stock0.000.000.00-0.010.000.000.00
Additional Paid-in Capital2.121.861.711.611.561.461.45
Shares Outstanding0.360.240.190.150.000.000.00
Total Stockholders' Equity0.150.090.120.110.160.12-0.03
Total Liabilities & Equity0.300.230.190.130.200.420.28